Literature DB >> 32884117

Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT.

Robert Pytlík1,2, Blanka Vacková3, Eva Konířová3, Marie Trnková3, Petra Blahovcová3, David Pohlreich3, Kamila Polgárová3, Pavel Klener3,4, Kateřina Benešová3, Kateřina Kopečková5, Jan Pirnos6, Marek Trněný3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32884117     DOI： 10.1038/s41409-020-01045-4

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.

Authors:  Rebecca L Elstrom; Peter Martin; Sandra Hurtado Rua; Tsiporah B Shore; Richard R Furman; Jia Ruan; Roger N Pearse; Morton Coleman; Tomer Mark; John P Leonard; Usama Gergis
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

2.  Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.

Authors:  Esa Jantunen; Carmen Canals; Alessandro Rambaldi; Gert Ossenkoppele; Bernardino Allione; Didier Blaise; Eulogio Conde; Hervè Tilly; Gordon Cook; Fiona Clark; Andrea Gallamini; Andrew Haynes; Nicolas Mounier; Peter Dreger; Michael Pfreundschuh; Anna Sureda
Journal:  Haematologica       Date:  2008-10-06       Impact factor: 9.941

3.  Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.

Authors:  Michael Crump; John Kuruvilla; Stephen Couban; David A MacDonald; Vishal Kukreti; C Tom Kouroukis; Morel Rubinger; Rena Buckstein; Kevin R Imrie; Massimo Federico; Nicola Di Renzo; Kang Howson-Jan; Tara Baetz; Leonard Kaizer; Michael Voralia; Harold J Olney; A Robert Turner; Jonathan Sussman; Annette E Hay; Marina S Djurfeldt; Ralph M Meyer; Bingshu E Chen; Lois E Shepherd
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

4.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

5.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

6.  Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.

Authors:  Lova Sun; Shuli Li; Areej El-Jawahri; Philippe Armand; Bimalangshu R Dey; David C Fisher; Eric D Jacobsen; Caron A Jacobson; Ann S LaCasce; Steven L McAfee; Thomas R Spitzer; Yi-Bin Chen; Zachariah DeFilipp
Journal:  Oncologist       Date:  2017-12-28

7.  Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.

Authors:  K Davison; B E Chen; V Kukreti; S Couban; A Benger; N L Berinstein; L Kaizer; P Desjardins; J Mangel; L Zhu; M S Djurfeldt; A E Hay; L E Shepherd; M Crump
Journal:  Ann Oncol       Date:  2017-03-01       Impact factor: 32.976

8.  Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.

Authors:  Gustaaf W van Imhoff; Andrew McMillan; Matthew J Matasar; John Radford; Kirit M Ardeshna; Kazimierz Kuliczkowski; WonSeog Kim; Xiaonan Hong; Jette Soenderskov Goerloev; Andrew Davies; María Dolores Caballero Barrigón; Michinori Ogura; Sirpa Leppä; Michael Fennessy; Qiming Liao; Bronno van der Holt; Steen Lisby; Anton Hagenbeek
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544

9.  Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.

Authors:  Christian Gisselbrecht; Bertram Glass; Nicolas Mounier; Devinder Singh Gill; David C Linch; Marek Trneny; Andre Bosly; Nicolas Ketterer; Ofer Shpilberg; Hans Hagberg; David Ma; Josette Brière; Craig H Moskowitz; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2010-07-26       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.